MHV68 latency modulates the host immune response to influenza A virus

Fumitake Saito1, Toshihiro Ito, Judith M Connett

  • 1Division of Pulmonary Medicine, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Inflammation
|June 29, 2013
PubMed

Insights

Latent murine gammaherpesvirus 68 infection enhances survival against influenza A virus. This protection is mediated by activated alveolar macrophages, reducing viral load and lung inflammation.

Area of Science:

  • Virology
  • Immunology
  • Pathogenesis

Background:

  • Murine gammaherpesvirus 68 (MHV68) is a model for human gammaherpesviruses, establishing lifelong latency.
  • Latent MHV68 infection has been linked to resistance against unrelated pathogens in secondary infections.

Purpose of the Study:

  • To investigate if latent MHV68 infection modulates the host immune response to influenza A virus.
  • To determine the role of alveolar macrophages in MHV68-mediated protection against secondary infections.

Main Methods:

  • Mice with established latent MHV68 infection were challenged with influenza A virus.
  • Influenza viral loads, lung pathology, and alveolar macrophage activation status were assessed.
  • Adoptive transfer of activated alveolar macrophages was performed to evaluate their protective role.

Main Results:

  • Mice with latent MHV68 infection exhibited significantly higher survival rates following influenza A virus challenge compared to controls.
  • Latent MHV68 infection resulted in reduced influenza viral loads and decreased lung inflammatory pathology.
  • Activated alveolar macrophages from latently infected mice conferred enhanced survival in recipient mice challenged with influenza A virus.

Conclusions:

  • Latent MHV68 infection confers significant protection against secondary influenza A virus infection.
  • Activated alveolar macrophages are a key mechanism underlying this protective effect.
  • MHV68 latency can reprogram macrophage function, offering resistance to unrelated viral pathogens.